Bone Biologics Q2 EPS Estimate Lowered by Zacks Small Cap
Bone Biologics Co. (NASDAQ:BBLG – Free Report) – Zacks Small Cap cut their Q2 2025 earnings per share estimates for shares of Bone Biologics in a report issued on Wednesday, June 11th. Zacks Small Cap analyst B. Sorensen now forecasts that the company will post earnings of ($1.93) per share for the quarter, down from […]
